Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Sorafenib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 8 Leukemia, Myeloid, Acute 3 Fibrolamellar hepatocellular carcinoma 2 Tongue Neoplasms 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors 1 Melanoma 1 Hepatoblastoma 1 Desmoplastic Small Round Cell Tumor 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

zanubrutinib 7 Rituximab 7 ibrutinib 4 venetoclax 3 ixazomib 3 pirtobrutinib 2 Specimen Handling 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CT-P10 2 Bortezomib 2 Biopsy 2 talquetamab 1 fludarabine 1 brexucabtagene autoleucel 1 acalabrutinib 1 Vincristine 1 Valganciclovir 1 Valacyclovir 1 Therapeutics 1 Thalidomide 1 Sirolimus 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Lenalidomide 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡